Literature DB >> 15028305

Sentinel-node biopsy for axillary staging in breast cancer: results from a large prospective German multi-institutional trial.

T Kuehn1, F D Vogl, G Helms, S V Pueckler, H Schirrmeister, R Strueber, K Koretz, R Kreienberg.   

Abstract

PURPOSE: To analyse the reliability of sentinel-node biopsy (SNB) in a multicentre setting and define conditions for the routine use of the procedure.
MATERIAL AND METHODS: SNB with consecutive axillary clearing was performed in 1124 breast cancer patients. The detection rate of a sentinel lymph node and its dependence on the choice of lymphography technique, patient selection, and technical procedure were analysed. The diagnostic performance of the sentinel-node method was compared to clinical, ultrasound-guided and histological staging. In order to study training effects all learning periods were included.
RESULTS: Twenty-two institutions with a total of 89 surgeons participated in the trial. The detection rate (overall: 85.2%) was found to be related to the applied lymphography technique, the experience of the institution and various technical factors of the procedure itself. The false-negative rate (FNR, overall: 8.2%) was independent of patient selection and technical features. The FNR did not depend on experience in the application of the method, but seemed related to surgical accuracy to detect sentinel nodes. Compared to conventional staging procedures (palpation, ultrasound) SNB yielded highly reproducible results for the prediction of the axillary status even in a multicentre setting involving surgeons with different training status.
CONCLUSION: SNB is suited as standard of care procedure. Measures of quality control appear more important than learning periods to minimize the FNR.

Entities:  

Mesh:

Year:  2004        PMID: 15028305     DOI: 10.1016/j.ejso.2003.11.016

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  10 in total

Review 1.  Sentinel node biopsy and axillary dissection in breast cancer: the evidence and its limits.

Authors:  Wolfgang Janni; Thorsten Kühn; Lukas Schwentner; Rolf Kreienberg; Tanja Fehm; Achim Wöckel
Journal:  Dtsch Arztebl Int       Date:  2014-04-04       Impact factor: 5.594

2.  Preoperative Scintigrams to Identify the Sentinel Lymph Node in Breast Cancer: a Waste of Time?

Authors:  N Sharma; A Pinto; A Notghi; M Sintler
Journal:  Indian J Surg       Date:  2013-10-27       Impact factor: 0.656

3.  Impact of patient- and disease-specific factors on SLNB in breast cancer patients. Are current guidelines justified?

Authors:  A Bembenek; J Fischer; H Albrecht; E Kemnitz; S Gretschel; U Schneider; S Dresel; P M Schlag
Journal:  World J Surg       Date:  2007-02       Impact factor: 3.352

4.  Sentinel node skills verification and surgeon performance: data from a multicenter clinical trial for early-stage breast cancer.

Authors:  Katherine E Posther; Linda M McCall; Peter W Blumencranz; William E Burak; Peter D Beitsch; Nora M Hansen; Monica Morrow; Lee G Wilke; James E Herndon; Kelly K Hunt; Armando E Giuliano
Journal:  Ann Surg       Date:  2005-10       Impact factor: 12.969

5.  Sentinel Lymph Node Biopsy in Early Breast Cancer.

Authors:  Thorsten Kühn
Journal:  Breast Care (Basel)       Date:  2011-06-14       Impact factor: 2.860

6.  Interstitial multicatheter HDR-brachytherapy as accelerated partial breast irradiation after second breast-conserving surgery for locally recurrent breast cancer.

Authors:  Georgios Chatzikonstantinou; Iosif Strouthos; Christian Scherf; Janett Köhn; Christine Solbach; Claus Rödel; Nikolaos Tselis
Journal:  J Radiat Res       Date:  2021-05-12       Impact factor: 2.724

7.  Sentinel Lymph Node Biopsy in Breast Cancer Patients by Means of Indocyanine Green Using the Karl Storz VITOM® Fluorescence Camera.

Authors:  Thomas Papathemelis; Evi Jablonski; Anton Scharl; Tanja Hauzenberger; Michael Gerken; Monika Klinkhammer-Schalke; Matthias Hipp; Sophia Scharl
Journal:  Biomed Res Int       Date:  2018-03-26       Impact factor: 3.411

8.  Axillary Surgery in Breast Cancer Patients Treated with Breast-Conserving Surgery at German Breast Cancer Centers Within the Last 14 Years - Comparison of a University Center and a Community Hospital.

Authors:  Amelie de Gregorio; Peter Widschwendter; Susanne Albrecht; Nikolaus de Gregorio; Thomas W P Friedl; Jens Huober; Wolfgang Janni; Florian K Ebner
Journal:  Geburtshilfe Frauenheilkd       Date:  2018-11-26       Impact factor: 2.915

9.  Three stage axillary lymphatic massage optimizes sentinel lymph node localisation using blue dye.

Authors:  Robert M Kirby; Abdul Basit; Quang T Nguyen; Anthony Jaipersad; Rebecca Billingham
Journal:  Int Semin Surg Oncol       Date:  2007-12-22

10.  Axillary recurrences after sentinel node (SLN) biopsy without complete axillary dissection in breast cancer patients.

Authors:  P Kristen; R Lorenz; M Gross; A Beck; M Sütterlin; C Reiners; J Dietl
Journal:  Br J Cancer       Date:  2005-03-14       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.